Total Funding
65
64
Total FundingSeries B raised
Growth Score 65 in past quarter
-12 pts
Heat Score 64 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
12466
Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.
Ilya Kupershmidt: Cofounder, Head of InformaticsPast Role: Xcell Biosciences, Founding CIO- Amin Ronaghi: Business OperationsPast Role: Phi-X Capital, Co-Founder & Managing Partner
About the Company
Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.
The company's platform specializes in molecular biology, biochemistry, microfluidics, integrated sensors, and genome sequencing, enabling scientists to create novel solutions to challenging biological issues.
Cellanome was
established in 2020 by Mostafa Ronaghi in Redwood City, California.